Literature DB >> 33398166

Targeting the mitochondria to block tumour growth.

Sarah Crunkhorn.   

Abstract

Entities:  

Year:  2021        PMID： 33398166     DOI： 10.1038/d41573-021-00001-1

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Small-molecule inhibitors of human mitochondrial DNA transcription.

Authors:  Nina A Bonekamp; Bradley Peter; Hauke S Hillen; Andrea Felser; Tim Bergbrede; Axel Choidas; Moritz Horn; Anke Unger; Raffaella Di Lucrezia; Ilian Atanassov; Xinping Li; Uwe Koch; Sascha Menninger; Joanna Boros; Peter Habenberger; Patrick Giavalisco; Patrick Cramer; Martin S Denzel; Peter Nussbaumer; Bert Klebl; Maria Falkenberg; Claes M Gustafsson; Nils-Göran Larsson
Journal:  Nature       Date:  2020-12-16       Impact factor: 49.962
  1 in total
  3 in total

Review 1.  Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities.

Authors:  Balaraman Kalyanaraman; Gang Cheng; Micael Hardy
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

Review 2.  Targeting Mitochondrial Metabolism and RNA Polymerase POLRMT to Overcome Multidrug Resistance in Cancer.

Authors:  Hui-Jing Yu; Guan-Li Xiao; Yu-Ying Zhao; Xin-Xin Wang; Rongfeng Lan
Journal:  Front Chem       Date:  2021-12-16       Impact factor: 5.221

3.  Combining PEGylated mito-atovaquone with MCT and Krebs cycle redox inhibitors as a potential strategy to abrogate tumor cell proliferation.

Authors:  Gang Cheng; Micael Hardy; Ming You; Balaraman Kalyanaraman
Journal:  Sci Rep       Date:  2022-03-24       Impact factor: 4.996
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.